文献速递神经肿瘤

磁靶向负载叶酸修饰超顺磁氧化铁纳米颗粒的自然杀伤细胞治疗胶质母细胞瘤的体内研究

The Potential of Magnetic Targeted Natural Killer Cell Therapy for Glioblastoma: An in Vivo Study of Natural Killer Cells Loaded With Low-Temperature Synthesized Folic Acid-Modified Superparamagnetic Iron Oxide Nanoparticles.
PubMed 文献 · Neurosurgery · 2025-09-19

本研究合成叶酸修饰的聚乙二醇化超顺磁氧化铁纳米颗粒(SPIONs-PEG-FA),用于磁化自然杀伤(NK)细胞,使其在外加磁场下向胶质母细胞瘤(GBM)部位聚集并保持细胞毒活性。体外实验评估安全性、细胞摄取和溶细胞活性,体内实验在GBM荷瘤小鼠中评估肿瘤靶向性和治疗疗效。结果显示负载SPIONs-PEG-FA的NK细胞安全有效,体内靶向性、溶细胞效率和总体安全性均改善。

要点

  • 叶酸修饰超顺磁氧化铁纳米颗粒可成功负载于NK细胞并保持其抗GBM细胞毒活性
  • 外加磁场引导下负载纳米颗粒的NK细胞在GBM荷瘤小鼠中肿瘤靶向性和溶细胞效率改善
  • 该磁靶向NK细胞疗法为GBM治疗提供潜在新策略

核心结论

  • 负载SPIONs-PEG-FA的NK细胞是靶向GBM治疗的有前景方法,体外和体内验证支持其改善治疗结局的潜力。

研究设计与样本

  • 研究合成SPIONs-PEG-FA并负载NK细胞,通过材料表征确认合成成功,体外评估安全性、摄取和溶细胞活性,体内在GBM荷瘤小鼠中评估靶向与疗效。

主要发现

  • SPIONs-PEG-FA负载NK细胞成功构建,体外证实对GBM肿瘤细胞安全有效,透射电镜验证NK细胞摄取纳米颗粒。
  • GBM荷瘤小鼠体内实验显示负载SPIONs-PEG-FA的NK细胞肿瘤靶向性改善、溶细胞效率增强且总体安全。

临床怎么用

  • 该磁靶向NK细胞疗法可能为GBM提供一种克服靶向难题的新策略,但尚需进一步临床转化验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Glioblastoma (GBM) is a highly malignant brain tumor with limited treatment options. While natural killer (NK) cell-based immunotherapy shows promise in cancer treatment, effective tumor targeting remains a challenge. This study investigates the use of folic acid-modified superparamagnetic iron oxide nanoparticles (SPIONs-PEG-FA) to magnetize NK cells, enabling them to accumulate at the tumor site under an external magnetic field while retaining their cytotoxic activity against GBM cells. METHODS: SPIONs-PEG-FA were synthesized using PEGylation and coprecipitation to ensure efficient NK cell uptake. Their successful synthesis was confirmed through material characterization, including X-ray diffraction, Fourier transform infrared spectroscopy, transmission electron microscopy, and dynamic light scattering. In vitro studies evaluated their safety, cellular uptake, and cytolytic activity, whereas in vivo experiments assessed tumor targeting and therapeutic efficacy in GBM-bearing mice. RESULTS: SPIONs-PEG-FA-loaded NK cells were successfully developed for targeted GBM therapy. In vitro studies confirmed their safety and effectiveness against GBM tumor cells, whereas transmission electron microscopy analysis verified the cellular uptake of SPIONs-PEG-FA by NK cells. In vivo experiments in GBM-bearing mice demonstrated improved tumor targeting, enhanced cytolytic efficiency, and overall safety of SPIONs-PEG-FA-loaded NK cells. CONCLUSION: SPIONs-PEG-FA-loaded NK cells represent a promising approach for targeted GBM therapy. Their successful synthesis and characterization, coupled with in vitro and in vivo validation, highlight their potential for improved therapeutic outcomes. This magnetic field-guided NK cell therapy offers a promising strategy for overcoming challenges in GBM treatment.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Lin PC, Liang YJ, Kuo WT, et al. The Potential of Magnetic Targeted Natural Killer Cell Therapy for Glioblastoma: An in Vivo Study of Natural Killer Cells Loaded With Low-Temperature Synthesized Folic Acid-Modified Superparamagnetic Iron Oxide Nanoparticles. Neurosurgery. 2025. PMID: 40970696. doi:10.1227/neu.0000000000003731

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。